![A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Graves' Hyperthyroidism and Graves' Orbitopathy in: European Thyroid Journal Volume 8 Issue 1 (2019) A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Graves' Hyperthyroidism and Graves' Orbitopathy in: European Thyroid Journal Volume 8 Issue 1 (2019)](https://etj.bioscientifica.com/view/journals/etj/8/1/images/ETJ494837_F02_B.jpeg)
A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Graves' Hyperthyroidism and Graves' Orbitopathy in: European Thyroid Journal Volume 8 Issue 1 (2019)
![PDF) Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study PDF) Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study](https://i1.rgstatic.net/publication/304715361_Quality-of-Life_Impairments_Persist_Six_Months_After_Treatment_of_Graves'_Hyperthyroidism_and_Toxic_Nodular_Goiter_A_Prospective_Cohort_Study/links/57a7438208aee07544c15277/largepreview.png)
PDF) Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study
Thyroid stimulating immunoglobulins in Graves' disease with goitre growth, low thyroxine and increasing triiodothyronine during
![No link between season of birth and subsequent development of Graves' disease or toxic nodular goitre. A nationwide Danish register-based study in: Endocrine Connections Volume 7 Issue 10 (2018) No link between season of birth and subsequent development of Graves' disease or toxic nodular goitre. A nationwide Danish register-based study in: Endocrine Connections Volume 7 Issue 10 (2018)](https://ec.bioscientifica.com/view/journals/ec/7/10/images/EC-18-0185fig1.jpeg)